Geographic Atrophy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Geographic Atrophy Market is expected to grow at a CAGR of 7% during the forecast period 2022-2028.

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD), a condition in which cells in the outer retina deteriorate. Areas where cells are atrophied develop demarcated atrophic lesions or blind spots in the field of vision due to loss of photoreceptors or retinal pigment epithelium (RPE). Areas where cells are atrophied create blind spots in the field of vision. This condition progresses gradually over time, is an irreversible loss of vision, and usually affects a person’s central vision. Early symptoms of this condition include the inability to see parts or letters when reading, or the inability to see small parts of the face when looking at people.

Market Segments

By Age Group

• Above 60 Years
• Above 75 Years

By Diagnosis

• Fundus Auto Fluorescence (FAF)
• Optical Coherence Tomography Angiography (OCT-A)
• Multifocal Electroretinography (mfERG)

By Therapeutic Agents Clinical Phase

• Late-stage (Phase III)
• Phase II
• Phase I
• Pre-clinical stage & Discovery candidates

Key Players

• Apellis Pharmaceuticals, Inc. (US)
• Iveric Bio (US)
• Alkeus Pharmaceuticals, Inc. (US)
• Hemera Biosciences LLC (US)
• Allegro Ophthalmics, LLC (US)
• Stealth BioTherapeutics (Cayman Islands)
• Gyroscope Therapeutics Limited (UK)
• Regenerative Patch Technologies, LLC (US)
• Hoffmann-La Roche AG (Switzerland)
• Genentech, Inc. (US)
• Gensight Biologics SA (France)

Scope of the Report

The research study analyzes the global Geographic Atrophy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Geographic Atrophy Market Report

1. What was the Geographic Atrophy Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Geographic Atrophy Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Geographic Atrophy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.